SEARCH · Engineering Papers

Results for “NEUTRALIZATION”

Search indexed NASA NTRS and DOE OSTI research on propulsion, heat transfer, battery materials and energy systems. Follow report and document links to the original sources.

SourceResearch connectionFrom yearThrough year

Quote a phrase for an exact phrase match. Source license links do not imply unrestricted reuse.

At least 541 records · Page 30

All sources NASA NTRS DOE OSTI

DOE OSTI2022

Structural basis for HCMV Pentamer recognition by neuropilin 2 and neutralizing antibodies

Human cytomegalovirus (HCMV) encodes multiple surface glycoprotein complexes to infect a variety of cell types. The HCMV Pentamer, composed of gH, gL, UL128, UL130, and UL131A, enhances entry into epithelial, endothelial, and myeloid cells by interacting with the cell surface receptor neuropilin 2 (NRP2). Despite the critical nature of this interaction, the molecular determinants that govern NRP2 recognition remain unclear. Here, we describe the cryo-EM structure of NRP2 bound to Pentamer. The high-affinity interaction between these proteins is calcium dependent and differs from the canonical carboxyl-terminal arginine (CendR) binding that NRP2 typically uses. We also determine the structures of four neutralizing human antibodies bound to the HCMV Pentamer to define susceptible epitopes. Two of these antibodies compete with NRP2 binding, but the two most potent antibodies recognize a previously unidentified epitope that does not overlap the NRP2-binding site. Collectively, these findings provide a structural basis for HCMV tropism and antibody-mediated neutralization.

59 BASIC BIOLOGICAL SCIENCES↗

DOE OSTI2022

Engineered ACE2-Fc counters murine lethal SARS-CoV-2 infection through direct neutralization and Fc-effector activities

Soluble angiotensin-converting enzyme 2 (ACE2) constitutes an attractive antiviral capable of targeting a wide range of coronaviruses using ACE2 as their receptor. Using structure-guided approaches, we developed a series of bivalent ACE2-Fcs harboring functionally and structurally validated mutations that enhance severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) receptor binding domain recognition by up to ~12-fold and remove angiotensin enzymatic activity. The lead variant M81 potently cross-neutralized SARS-CoV-2 variants of concern (VOCs), including Omicron, at subnanomolar half-maximal inhibitory concentration and was capable of robust Fc-effector functions, including antibody-dependent cellular cytotoxicity, phagocytosis, and complement deposition. When tested in a stringent K18-hACE2 mouse model, Fc-enhanced ACE2-Fc delayed death by 3 to 5 days or effectively resolved lethal SARS-CoV-2 infection in both prophylactic and therapeutic settings via the combined effects of neutralization and Fc-effector functions. These data add to the demonstrated utility of soluble ACE2 as a valuable SARS-CoV-2 antiviral and indicate that Fc-effector functions may constitute an important component of ACE2-Fc therapeutic activity.

60 APPLIED LIFE SCIENCES↗

DOE OSTI2020

An ultrapotent synthetic nanobody neutralizes SARS-CoV-2 by stabilizing inactive Spike

The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) virus enters host cells via an interaction between its Spike protein and the host cell receptor angiotensin-converting enzyme 2 (ACE2). By screening a yeast surface-displayed library of synthetic nanobody sequences, we developed nanobodies that disrupt the interaction between Spike and ACE2. Cryo–electron microscopy (cryo-EM) revealed that one nanobody, Nb6, binds Spike in a fully inactive conformation with its receptor binding domains locked into their inaccessible down state, incapable of binding ACE2. Affinity maturation and structure-guided design of multivalency yielded a trivalent nanobody, mNb6-tri, with femtomolar affinity for Spike and picomolar neutralization of SARS-CoV-2 infection. mNb6-tri retains function after aerosolization, lyophilization, and heat treatment, which enables aerosol-mediated delivery of this potent neutralizer directly to the airway epithelia.

60 APPLIED LIFE SCIENCES↗

DOE OSTI2021

Broad betacoronavirus neutralization by a stem helix–specific human antibody

Targeting a range of betacoranaviruses In the past 20 years, three highly pathogenic β-coronaviruses have crossed from animals to humans, including the most recent: severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). A spike protein that decorates these viruses has an S1 domain that binds host cell receptors and an S2 domain that fuses the viral and cell membranes to allow cell entry. The S1 domain is the target of many neutralizing antibodies but is more genetically variable than S2, and antibodies can exert selective pressure, leading to resistant variants. Pinto et al . identified five monoclonal antibodies that interact with a helix in the S2 domain. The most broadly neutralizing antibody inhibited all β-coronavirus subgenera and reduced viral burden in hamsters infected with SARS-CoV-2. —VV

59 BASIC BIOLOGICAL SCIENCES↗

DOE OSTI2022

Vaccination before or after SARS-CoV-2 infection leads to robust humoral response and antibodies that effectively neutralize variants

Current coronavirus disease 2019 (COVID-19) vaccines effectively reduce overall morbidity and mortality and are vitally important to controlling the pandemic. Individuals who previously recovered from COVID-19 have enhanced immune responses after vaccination (hybrid immunity) compared with their naïve-vaccinated peers; however, the effects of post-vaccination breakthrough infections on humoral immune response remain to be determined. Here, we measure neutralizing antibody responses from 104 vaccinated individuals, including those with breakthrough infections, hybrid immunity, and no infection history. We find that human immune sera after breakthrough infection and vaccination after natural infection broadly neutralize SARS-CoV-2 (severe acute respiratory coronavirus 2) variants to a similar degree. Although age negatively correlates with antibody response after vaccination alone, no correlation with age was found in breakthrough or hybrid immune groups. Together, our data suggest that the additional antigen exposure from natural infection substantially boosts the quantity, quality, and breadth of humoral immune response regardless of whether it occurs before or after vaccination.

60 APPLIED LIFE SCIENCES↗

DOE OSTI2020

New constraints on heavy neutral leptons from Super-Kamiokande data

Abstract Heavy neutral leptons are predicted in many extensions of the Standard Model with massive neutrinos. If kinematically accessible, they can be copiously produced from kaon and pion decays in atmospheric showers, and subsequently decay inside large neutrino detectors. We perform a search for these long-lived particles using Super-Kamiokande multi-GeV neutrino data and derive stringent limits on the mixing with electron, muon and tau neutrinos as a function of the long-lived particle mass. We also present the limits on the branching ratio versus lifetime plane, which are helpful in determining the constraints in non-minimal models where the heavy neutral leptons have new interactions with the Standard Model.

72 PHYSICS OF ELEMENTARY PARTICLES AND FIELDS↗

DOE OSTI2024

Search for flavour-changing neutral-current couplings between the top quark and the Higgs boson in multi-lepton final states in 13 TeV pp collisions with the ATLAS detector

A search is presented for flavour-changing neutral-current interactions involving the top quark, the Higgs boson and an up-type quark (q = u, c ) with the ATLAS detector at the Large Hadron Collider. The analysis considers leptonic decays of the top quark along with Higgs boson decays into two W bosons, two Z bosons or a τ + τ - pair. It focuses on final states containing either two leptons (electrons or muons) of the same charge or three leptons. The considered processes are $t\bar{t}$ and Ht production. For the $t\bar{t}$ production, one top quark decays via $t\rightarrow Hq$. The proton–proton collision data set analysed amounts to (140 fb -1 ) at $(\sqrt{s}={13}\,\hbox {TeV})$. No significant excess beyond Standard Model expectations is observed and upper limits are set on the $t\rightarrow Hq$ branching ratios at 95 % confidence level, amounting to observed (expected) limits of $\mathcal {B}(t\rightarrow Hu)<2.8\,(3.0) \times 10^{-4}$ and $\mathcal {B}(t\rightarrow Hc)<3.3\,(3.8) \times 10^{-4}$. Combining this search with other searches for tHq flavour-changing neutral-current interactions previously conducted by ATLAS, considering $H\rightarrow b\bar{b}$ and $H\rightarrow \gamma \gamma$ decays, as well as $H\rightarrow \tau ^{+}\tau ^{-}$ decays with one or two hadronically decaying τ-leptons, yields observed (expected) upper limits on the branching ratios of $\mathcal {B}(t\rightarrow Hu)<2.6\,(1.8) \times 10^{-4}$ and $\mathcal {B}(t\rightarrow Hc)<3.4\,(2.3) \times 10^{-4}$.

72 PHYSICS OF ELEMENTARY PARTICLES AND FIELDS↗

DOE OSTI2023

A new class of antibodies that overcomes a steric barrier to cross-group neutralization of influenza viruses

Antibody titers that inhibit the influenza virus hemagglutinin (HA) from engaging its receptor are the accepted correlate of protection from infection. Many potent antibodies with broad, intra-subtype specificity bind HA at the receptor binding site (RBS). One barrier to broad H1-H3 cross-subtype neutralization is an insertion (133a) between positions 133 and 134 on the rim of the H1 HA RBS. We describe here a class of antibodies that overcomes this barrier. These genetically unrestricted antibodies are abundant in the human B cell memory compartment. Analysis of the affinities of selected members of this class for historical H1 and H3 isolates suggest that they were elicited by H3 exposure and broadened or diverted by later exposure(s) to H1 HA. RBS mutations in egg-adapted vaccine strains cause the new H1 specificity of these antibodies to depend on the egg adaptation. The results suggest that suitable immunogens might elicit 133a-independent, H1-H3 cross neutralization by RBS-directed antibodies.

60 APPLIED LIFE SCIENCES↗

DOE OSTI2023

Broadly neutralizing humanized SARS-CoV-2 antibody binds to a conserved epitope on Spike and provides antiviral protection through inhalation-based delivery in non-human primates

The COVID-19 pandemic represents a global challenge that has impacted and is expected to continue to impact the lives and health of people across the world for the foreseeable future. The rollout of vaccines has provided highly anticipated relief, but effective therapeutics are required to further reduce the risk and severity of infections. Monoclonal antibodies have been shown to be effective as therapeutics for SARS-CoV-2, but as new variants of concern (VoC) continue to emerge, their utility and use have waned due to limited or no efficacy against these variants. Furthermore, cumbersome systemic administration limits easy and broad access to such drugs. As well, concentrations of systemically administered antibodies in the mucosal epithelium, a primary site of initial infection, are dependent on neonatal Fc receptor mediated transport and require high drug concentrations. To reduce the viral load more effectively in the lung, we developed an inhalable formulation of a SARS-CoV-2 neutralizing antibody binding to a conserved epitope on the Spike protein, ensuring pan-neutralizing properties. Administration of this antibody via a vibrating mesh nebulization device retained antibody integrity and resulted in effective distribution of the antibody in the upper and lower respiratory tract of non-human primates (NHP). In comparison with intravenous administration, significantly higher antibody concentrations can be obtained in the lung, resulting in highly effective reduction in viral load post SARS-CoV-2 challenge. This approach may reduce the barriers of access and uptake of antibody therapeutics in real-world clinical settings and provide a more effective blueprint for targeting existing and potentially emerging respiratory tract viruses.

60 APPLIED LIFE SCIENCES↗

DOE OSTI2021

LLNL - WRF-LES - Neutral - TTU

This dataset includes large-eddy simulation (LES) output from a neutrally stratified atmospheric boundary layer (ABL) simulation of observations at the SWIFT tower near Lubbock, Texas on Aug. 17, 2012. The dataset was used to assess LES models for simulation of canonical neutral ABL. The dataset can be used for comparison with other LES and computational fluid dynamics model outputs.

17 WIND ENERGY↗

DOE OSTI2021

ANL - WRF-LES - Neutral - TTU

17 WIND ENERGY↗

DOE OSTI2021

LANL - WRF-LES - Neutral - TTU

17 WIND ENERGY↗

DOE OSTI2021

NREL - SOWFA - Neutral - TTU

17 WIND ENERGY↗

DOE OSTI2021

LANL - Neutral - TTU

17 WIND ENERGY↗

DOE OSTI2021

Phosgene Neutralization Chemistry for the Explosive Destruction System (EDS)

This report summarizes activities at Sandia National Laboratories as part of the Explosive Destruction System (EDS) Phase 3 (P3) System design. An exploration of chemical neutralization strategies of phosgene was conducted for safe disposal of recovered mortars and M79 1000 lb. bombs filled with carbonyl dichloride "phosgene" or "CG agent" (molecular formula = COCl 2 ). The incumbent strategy utilized aqueous sodium hydroxide was found to be the worst-case scenario, producing enough CO 2 gas that would cause an unacceptable pressure and temperature spike. Several chemical neutralization strategies were evaluated based on criteria set by the operating envelope of the P3 design. In the end, it was determined that a pure solution of N-methyl ethanolamine (MeEA) or 90% monoethanolamine (MEA)(aqueous) provided the best balance reaction profile, cost, and safety.

36 MATERIALS SCIENCE↗

DOE OSTI2021

Basic Energy Sciences Roundtable: Foundational Science for Carbon-Neutral Hydrogen Technologies

The amount of molecular hydrogen used worldwide is enormous; about 70 million metric tons are produced globally every year, with approximately 10 million metric tons produced within the U.S. alone. 1 Hydrogen is used primarily by the industrial sector for oil refining; chemical production, especially for ammonia; steel manufacturing; and transportation fuels. With the recent announcement of the Hydrogen Shot, the first U.S. Department of Energy (DOE) Energy Earthshot, the DOE declared a near-term focus on “accelerating breakthroughs of more abundant, affordable, and reliable clean energy solutions within the decade.” Consequently, there is a compelling need for novel approaches to enable hydrogen processes and technologies that do not emit carbon dioxide (i.e., are carbon-neutral). Innovative hydrogen research and development is required to impact how hydrogen is produced, stored, transported, converted, and used. Although progress has been made over the previous two decades, fundamental research can play a critical role in overcoming the technical hurdles that continue to limit implementation of economically viable systems and processes for carbon-neutral hydrogen technologies.

08 HYDROGEN↗

DOE OSTI2022

What is Water's Role in a Carbon Neutral Future? A Summary of Findings from a Webinar Series

There has been ever-growing interest and engagement regarding net-zero and carbon neutrality goals, with many nations committing to steep emissions reductions by mid-century. Although water plays critical roles in various sectors, there has been a distinct gap in discussions to date about the role of water in the transition to a carbon neutral future. To address this need, a webinar was convened in April 2022 to gain insights into how water can support or influence active strategies for addressing emissions activities across energy, industrial, and carbon sectors. The webinar presentations and discussions highlighted various nuances of direct and indirect water use both within and across technology sectors (Figure ES-1). For example, hydrogen and concrete production, water for mining, and inland waterways transportation are all heavily influenced by the energy sources used (fossil fuels vs. renewable sources) as well as local resource availabilities. Algal biomass, on the other hand, can be produced across diverse geographies (terrestrial to sea) in a range of source water qualities, including wastewater and could also support pollution remediation through nutrient and metals recovery. Finally, water also influences carbon dynamics and cycling within natural systems across terrestrial, aquatic, and geologic systems. These dynamics underscore not only the critical role of water within the energy-water nexus, but also the extension into the energy-watercarbon nexus.

54 ENVIRONMENTAL SCIENCES↗

DOE OSTI2022

An Electron-Beam Ion-Neutralization Diagnostic for the Scorpius Radiography Accelerator

Electron beam spilling onto the beam pipe can produce positive ions that are accelerated inward into the beam body by its space charge. These ions partially neutralize the space charge, thereby causing the beam to be mismatched to the magnetic fields used for transport. A diagnostic of neutralization effects has been used on present accelerators, and in this note the feasibility of its use on a future accelerator is assessed.

43 PARTICLE ACCELERATORS↗